The Indianapolis-based drugmaker said it would take a charge of 23 cents a share in the third quarter to cover restructuring costs and asset impairment.
Lilly said about 700 employees at its Tippecanoe Laboratories facility in Lafayette, Indiana, would be offered new employment at Evonik. The plant produces active pharmaceutical ingredients and specialty chemicals.
